Good news and a solid update. The press release to me highlights not only the advantages of Generex’s Ii-Key platform, but the complexities of dealing with the FDA. Especially, when you barely have a budget and as shareholders we don’t like shares needing to be used as currency. Dr Fauci really needs to expand his scope of avenues to eradicate, never mind pacify, Covid and likewise pandemics beyond a limited dead end of RNA, mRNA and DNA vaccines. They need to add Ii-Key to the basket.